FDA says Reynolds withdraws modified-risk applications for 6 Camel Snus  styles

FDA says Reynolds withdraws modified-risk applications for 6 Camel Snus styles

4.5
(749)
Write Review
More
$ 21.00
Add to Cart
In stock
Description

The Food and Drug Administration disclosed Thursday that R.J. Reynolds Tobacco Co. has requested the withdrawal of modified-risk tobacco product applications for six Camel Snus flavored products.
In Tunisia, more than 50 people have been in prison without trial for months for alleged conspiracy against state security or under a decree punishing the spreading of false information. Most of them are political opponents of President Kais Saied and the Ministry of justice has not been commenting on the cases publicly. For the families and lawyers of the prisoners, waiting for trials is becoming more and more trying. Lilia Blaise, Hamdi Tlili and Fadil Aliriza report.

Newer Nicotine and Tobacco Products: British American Tobacco - TobaccoTactics

bti-20221231

RJ Reynolds Tobacco Co. Seeks Modified Risk Classification for Camel Snus

IJERPH, Free Full-Text

IJERPH, Free Full-Text

Smoking, Tobacco and Cigarette News

IJERPH, Free Full-Text

FDA Updates Reynolds MRTP – Tobacco Reporter

FDA authorizes Swedish Match to advertise snus as less harmful than cigarettes

FDA Grants First-Ever Modified Risk Orders to General Snus

R.J. Reynolds Pivots to New Cigarette Pitches as Flavor Ban Takes Effect - The New York Times

New Camel SNUS Ads: Let it Snus, FDA! - SnusCENTRAL

R.J. Reynolds Tobacco makes significant step on tobacco harm reduction; FDA to continue its evaluation on modified-risk claims for Camel Snus